title: Chronic rhinosinusitis: New understanding of specific and general Quality of life scores.
abstract: Our goal in treating chronic rhinosinusitis (CRS) is to reduce sinonasal symptoms and improve quality of life (QoL). In patients with CRS, sinonasal symptoms have a significant impact on QoL. Various validated measures exist to quantify QoL such as the 22-item Sinonasal Outcomes Test (SNOT- 22) and MSNOT-20 Young Persons Questionnaire (MSYPQ) specific to CRS, while others measure general QoL, such as the EuroQol 5-Dimensional general health-related QoL survey (EQ5D).
authors.affiliation: ERS juniors.
authors.forename: A
authors.initials: A
authors.lastname: Slovick
authors.affiliation: ERS juniors.
authors.forename: M
authors.initials: M
authors.lastname: Cornet
authors.affiliation: ERS juniors.
authors.forename: P
authors.initials: P
authors.lastname: Surda
authors.affiliation: ERS juniors.
authors.forename: P V
authors.initials: PV
authors.lastname: Tomazic
mesh_terms: D000287:Administration, Topical; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use*; D018441:Biofilms; D002908:Chronic Disease; D004724:Endoscopy / Q000009:adverse effects / Q000379:methods*; D006801:Humans; D055556:Nasal Lavage / Q000379:methods*; D011788:Quality of Life; D012220:Rhinitis / Q000628:therapy*; D012852:Sinusitis / Q000628:therapy*; D019291:Skull Base / Q000293:injuries; D011795:Surveys and Questionnaires; D007507:Therapeutic Irrigation / Q000379:methods; D014993:Xylitol / Q000627:therapeutic use*
chemical_list: D000305:Adrenal Cortex Hormones; D014993:Xylitol